A method for preparing sodium chondroitin sulfate
By employing low-temperature microenzymatic hydrolysis and a two-stage membrane gradient purification process, the problems of high-temperature degradation and molecular weight inconsistency in the preparation of chondroitin sulfate sodium have been solved, achieving the preparation of high-purity, high-activity chondroitin sulfate sodium with green and environmentally friendly characteristics.
Patent Information
- Application Number
- CN202611415052.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-12
- Publication Date
- 2026-11-10
AI Technical Summary
Existing methods for preparing sodium chondroitin sulfate suffer from problems such as product degradation due to high temperatures and strong alkalis, uneven molecular weight distribution, incomplete removal of impurities, and poor batch stability, making it difficult to achieve green, lightweight, and efficient preparation.
The process employs low-temperature microenzymatic hydrolysis combined with bi-stage membrane gradient purification and alcohol-free in-situ sodium salt fixation. Through enzymatic hydrolysis with compound protease, ultrafiltration-nanofiltration membrane purification, and weak salt buffer ion exchange, high temperatures and organic solvents are avoided, thus maintaining the integrity of the polysaccharide backbone and the uniformity of molecular weight distribution.
It has achieved the preparation of high-purity, high-molecular-weight, and highly active chondroitin sulfate sodium with low degradation rate, uniform molecular weight distribution, good batch stability, and is green and environmentally friendly.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] This application relates to the technical field of chondroitin sulfate sodium, and in particular to a method for preparing chondroitin sulfate sodium. Background Technology
[0002] Chondroitin sulfate sodium is a natural high-molecular-weight glycosaminoglycan polysaccharide sodium salt with excellent biocompatibility, structural stability, and biological activity, making it a widely used natural polysaccharide raw material. Chondroitin sulfate sodium is widely found in connective tissues such as cartilage, tendons, ligaments, and blood vessel walls in humans and animals. It possesses physiological activities such as repairing articular cartilage, anti-inflammatory and analgesic effects, and regulating blood lipids, and is widely used in the fields of medicine, health foods, and food additives.
[0003] Existing industrial preparation processes mainly fall into three categories: strong alkali high-temperature hydrolysis, conventional long-term enzymatic hydrolysis, and repeated ethanol precipitation. These processes generally suffer from the following technical defects: 1. High-temperature and strong alkali processes easily cause the breakage of polysaccharide glycosidic bonds, resulting in severe product degradation, a decrease in the proportion of effective high-molecular-weight components, and poor product activity; 2. Traditional enzymatic hydrolysis often employs high doses and long durations, easily leading to excessive hydrolysis of polysaccharides and disordered molecular weight distribution; 3. The repeated ethanol precipitation process has low safety, high cost, and easily leaves solvent residues, and can easily cause uneven aggregation of polysaccharide fragments; 4. Traditional processes do not thoroughly remove impurities, resulting in poor batch stability and large fluctuations in purity.
[0004] In summary, existing methods for preparing sodium chondroitin sulfate generally suffer from problems such as large amounts of organic solvents used, heavy environmental pollution, product degradation due to high temperatures / strong acids and alkalis, uneven molecular weight distribution, cumbersome production processes, and high levels of residual proteins. It is difficult to achieve a lightweight preparation process that is minimally damaging, solvent-free, purified at room temperature, and green and controllable.
[0005] Therefore, developing a green preparation method that is mild throughout the process, free of organic solvents, can maintain the integrity of the high molecular weight backbone of chondroitin sulfate and the uniform molecular weight distribution, and has a high extraction yield is of great practical significance. Summary of the Invention
[0006] To address the problems of severe degradation, cumbersome processes, solvent residue, and batch instability in existing technologies, this application provides a method for preparing chondroitin sulfate sodium. This application abandons the traditional high-temperature strong alkali, large-volume alcohol precipitation, and high-dose enzymatic hydrolysis process, and adopts a novel process system of low-temperature microenzymatic extraction combined with room-temperature gradient purification using a two-stage membrane and alcohol-free in-situ sodium salt shaping, to achieve industrial-scale preparation with low degradation, high purity, green safety, and batch stability.
[0007] This application provides a method for preparing chondroitin sulfate sodium, using the following technical solution: A method for preparing chondroitin sulfate sodium includes the following steps: S1. Low-temperature clean pretreatment: The animal cartilage raw material is crushed, washed, and degreased at low temperature to obtain clean cartilage raw material; S2. Controlled microenzymatic hydrolysis extraction: The clean cartilage raw material is dispersed in a buffer aqueous solution, stirred, and subjected to low-temperature enzymatic hydrolysis using a compound protease. The crude extract is obtained by filtration to remove residue. S3. Membrane gradient fractionation purification: The crude extract is purified by ultrafiltration-nanofiltration dual-stage membrane gradient purification to obtain a purified polysaccharide concentrate; S4, alcohol-free green sodium salt conversion: ion exchange is carried out using a weak salt buffer system; S5. Low-temperature purification and finalization: Chondroitin sulfate sodium is obtained by aseptic filtration and low-temperature vacuum drying.
[0008] By employing the above technical solutions, the specific surface area of the cartilage material is increased through pulverization, allowing the subsequent enzymatic hydrolysate to fully penetrate and improving extraction efficiency. Low-temperature defatting removes surface oils and soluble impurities, preventing collagen denaturation and shrinkage or fat oxidation and rancidity caused by high temperatures, thereby protecting the natural structure of proteoglycans in the cartilage matrix and preparing for subsequent precise enzymatic hydrolysis.
[0009] A buffered aqueous solution maintains a stable pH in the system, preventing the hydrolysis and detachment of the sulfate ester groups of chondroitin sulfate and protecting the integrity of the polysaccharide. Enzymatic hydrolysis using a complex protease breaks down the proteoglycan-linked peptide chains, avoiding excessive proteolysis that could damage the polysaccharide backbone of chondroitin sulfate, and gently releasing the crude chondroitin sulfate polysaccharide solution.
[0010] A two-stage membrane gradient purification process using ultrafiltration and nanofiltration is employed. The ultrafiltration membrane physically removes impurities such as proteins, colloids, small molecule degradation fragments, and pigments at room temperature, enriching the complete high-molecular-weight chondroitin sulfate polysaccharide component. The nanofiltration membrane further removes small molecule salts and water, dehydrating and concentrating the feed solution to increase the polysaccharide concentration.
[0011] Ion exchange is used to achieve in-situ conversion of chondroitin sulfate to sodium chondroitin sulfate, without the use of organic solvents or drastic acid-base adjustments. Aseptic filtration and a low-temperature environment prevent high temperatures from degrading the chondroitin sulfate polysaccharide and causing the loss of sulfate groups, resulting in sodium chondroitin sulfate. The obtained sodium chondroitin sulfate is a high-molecular-weight polysaccharide with a degree of polymerization ≥6, featuring an intact main chain, low degradation rate, high purity, and uniform molecular weight distribution. This ultimately yields high-purity, high-molecular-weight, and highly active sodium chondroitin sulfate.
[0012] Preferably, the complex protease is composed of trypsin, papain, and flavor protease in a mass ratio of 1:0.1-0.2:0.4-0.6.
[0013] By adopting the above technical solution, trypsin preferentially hydrolyzes the lysine and arginine sites in the core protein of proteoglycan, directionally cleaving the protein backbone of proteoglycan, and dissociating and releasing the chondroitin sulfate glycan chain from the protein-calcium phosphate matrix.
[0014] Papain hydrolyzes some of the collagen, denatured proteins, and hydrophobic proteins in cartilage, breaking down the cartilage fibrous network structure and further releasing the encapsulated proteoglycans. Flavor proteases further degrade the large polypeptide molecules produced by the two endonucleases into smaller, shorter peptides, further improving product purity.
[0015] The combination of these three enzymes enables controlled microenzymatic hydrolysis. Trypsin targets and degrades the core protein of proteoglycans, releasing chondroitin sulfate. Papain assists in the degradation of cartilage collagen fibers, disrupting the dense matrix structure. Flavor protease degrades the large polypeptides generated by enzymatic hydrolysis into small peptides, facilitating subsequent membrane separation and removal. The synergistic effect of these three enzymes achieves efficient extraction while avoiding excessive enzymatic hydrolysis that could lead to the degradation of chondroitin sulfate polysaccharide chains, thus reducing the level of protein impurities in the liquid.
[0016] Preferably, the trypsin is pretreated, hydroxyapatite nanowires are dispersed in an ethanol / water mixed solution, mesoporous nano-silica is added, and the mixture is centrifuged, washed, and dried to obtain a composite carrier. The composite carrier was dispersed in phosphate buffer, trypsin was added, and after stirring, glutaraldehyde was added for cross-linking. After centrifugation and washing, immobilized trypsin was obtained.
[0017] By adopting the above technical solution, hydroxyapatite has abundant surface hydroxyl groups and good biocompatibility. It can bind to proteins through hydrogen bonds and electrostatic interactions, and has an affinity for and adsorption capacity for proteins. At the same time, it can regulate the local microenvironment and maintain trypsin activity.
[0018] Mesoporous silica nanofibers possess a high specific surface area and an ordered mesoporous structure, providing a large attachment surface for trypsin. Their pores can also accommodate enzyme molecules, serving a physical confinement and protection function. Hydroxyapatite nanowires loaded onto mesoporous silica provide a stable, high specific surface area composite carrier for subsequent enzyme immobilization.
[0019] Trypsin is adsorbed onto the mesoporous channels and surface of the composite carrier, and glutaraldehyde enables covalent bonding between the enzyme and the carrier, resulting in immobilized trypsin. This composite carrier utilizes mesoporous silica to provide high loading sites; the adsorption-covalent cross-linking approach ensures enzyme loading while reducing enzyme leakage, improving the stability and reusability of the trypsin. The stable immobilized enzyme enables more precise and gentler enzymatic hydrolysis, achieving the goal of breaking proteoglycan-linked peptide chains without disintegrating the polysaccharide backbone.
[0020] Preferably, the papain is treated by dissolving chitosan and amino acids in acetic acid solution-deionized water, mixing them, adding papain, and then adding genipin dropwise while stirring to form nanogel particles. After centrifugation and washing, the encapsulated papain is obtained.
[0021] By adopting the above technical solution, chitosan is used as the backbone material for constructing gels. The amino groups on its molecular chain enable subsequent cross-linking reactions, and the amino acids assist in cross-linking sites, providing a milder encapsulation environment for enzyme molecules.
[0022] Papain was added to the chitosan / amino acid mixture, and genipin was added dropwise while stirring. Genipin reacted with the amino groups on the chitosan molecules to form a stable three-dimensional network structure. Papain molecules were physically embedded in this continuously forming gel network and thus immobilized.
[0023] Genipin undergoes covalent cross-linking with chitosan and the amino groups of amino acids to form in-situ encapsulated papain nanogel particles, yielding encapsulated papain. In-situ encapsulation of papain using a three-dimensional polymer network enhances the enzyme's environmental stability. The nanogel structure facilitates substrate mass transfer, resulting in high enzyme activity retention and excellent biocompatibility.
[0024] Preferably, the flavor protease is treated by dissolving the flavor protease in an aqueous solution of diatomaceous earth, stirring until homogeneous, adding glutaraldehyde, continuing to stir, adding a metal-organic framework material, stirring at room temperature, centrifuging to collect the precipitate, washing, and obtaining the treated flavor protease.
[0025] By adopting the above technical solution, flavor protease molecules dissolve in the aqueous phase and come into full contact with diatomaceous earth particles. Relying on van der Waals forces, hydrogen bonds, and electrostatic interactions, some of the enzyme proteins are first adsorbed onto the pores and surface of the diatomaceous earth.
[0026] Metal-organic frameworks (MOFs) possess a regular microporous cage-like structure, a large specific surface area, and a charged surface. They can capture flavor protease molecules through electrostatic adsorption and cage confinement effects, encapsulating the enzyme within the cages. This ensures sufficient diffusion and adsorption of enzyme molecules on the surface and pores of the diatomaceous earth / MOF composite particles, achieving enzyme loading on the composite carrier.
[0027] Glutaraldehyde binds to the active amino groups on the surface of diatomaceous earth and to the lysine amino groups on the surface of flavor protease proteins, covalently anchoring the enzyme to the diatomaceous earth carrier. The metal-organic framework provides a high specific surface area and microporous cages, increasing the enzyme loading capacity. Diatomaceous earth, as the framework support, improves the sedimentation performance of the composite particles and inhibits the aggregation of metal-organic framework nanoparticles.
[0028] The flavor protease is covalently bonded to diatomaceous earth via the dialdehyde group of glutaraldehyde. The processed flavor protease is obtained by utilizing the porous adsorption properties of diatomaceous earth and the large specific surface area and microporous cage confinement effect of the metal-organic framework. This process first covalently cross-links and then composites with the metal-organic framework; the synergistic effect of covalent bonding and microporous physical confinement reduces enzyme leakage and loss while better preserving enzyme catalytic activity.
[0029] Preferably, in step S1, the particle size is 20-40 mesh, and the degreasing is carried out by stirring and rinsing with low-temperature clean water at a temperature of 15-25℃.
[0030] By adopting the above technical solution, the particle size is controlled at 20-40 mesh, and the size of the cartilage particles is moderate: the particles are not too fine, so as to avoid the formation of fine colloidal residue during subsequent S2 enzymatic hydrolysis filtration, which would cause filter cake caking, slow filtration, and membrane system blockage; the particles are also not too large, so as to prevent insufficient contact area for enzymatic hydrolysis and a decrease in the dissolution rate of chondroitin sulfate.
[0031] The temperature is maintained at 15-25℃ to avoid denaturation of chondroitin sulfate polysaccharide chains and loss of sulfate ester groups, thus ensuring the molecular weight and activity of the target product. The stirring and rinsing process relies on mechanical water flow to wash away free fats, oils, blood, soluble proteins, and fine calcium phosphate suspended particles from the interstitial spaces into the aqueous phase, which are then discharged with the rinse water, achieving degreasing and impurity removal. This method requires no organic solvents or high-temperature cooking, and is a physical degreasing process.
[0032] Preferably, in step S2, the buffer aqueous solution has a pH of 6.8-7.5 and the enzymatic hydrolysis temperature is 32-38℃.
[0033] By employing the above technical solution, this pH range is the optimal activity range for the complex protease, which can maximize enzyme activity, efficiently degrade the core protein and other proteins connecting chondroitin sulfate in cartilage, break down the dense structure of proteoglycans, and promote the full dissolution of chondroitin sulfate polysaccharide chains. The enzymatic hydrolysis temperature ensures a stable and efficient enzymatic hydrolysis reaction, thereby improving the chondroitin sulfate extraction yield.
[0034] This yields a crude extract with low impurity content and intact polysaccharide structure, providing a high-quality feed solution for subsequent two-stage membrane gradient purification and sodium alkoxide-free conversion, ensuring the purity, molecular weight, and stability of the finished product from the source.
[0035] Preferably, in step S4, the pH of the weak salt buffer system is 6.9-7.6, and the pH fluctuation of the system is ≤±0.3.
[0036] By adopting the above technical solution, under ethanol-free aqueous phase conditions, sodium ions are provided by a weak salt buffer system, and slow ion replacement is achieved under strictly controlled pH conditions (6.9-7.6, fluctuation ≤±0.3) to convert chondroitin sulfate calcium magnesium salt into chondroitin sulfate sodium. Polysaccharide degradation, sulfate ester shedding, and product salting-out precipitation are avoided throughout the process, resulting in a fully replaced and structurally intact chondroitin sulfate sodium solution, providing a qualified solution for subsequent aseptic filtration and low-temperature drying.
[0037] Preferably, the drying temperature in step S5 is -18 to 5°C.
[0038] By adopting the above technical solution, low-temperature vacuum drying avoids high-temperature degradation. The moisture in the system is removed in a low-temperature vacuum environment, and the complete polysaccharide chains and sulfate ester groups of sodium chondroitin sulfate are preserved to the greatest extent, resulting in a loose, easily soluble sodium chondroitin sulfate product with excellent color.
[0039] Secondly, the application of chondroitin sulfate sodium prepared by the method provided in this application in the fields of food, health products, cosmetics, and biomedicine.
[0040] In summary, this application has the following beneficial effects: 1. The chondroitin sulfate sodium of this application is a high molecular weight polysaccharide with a degree of polymerization ≥6. The polysaccharide backbone is intact, has low degradation degree, high purity, and uniform molecular weight distribution. This ultimately achieves high-purity, high-molecular-weight, and highly active chondroitin sulfate sodium.
[0041] 2. This application employs a dual-stage membrane gradient purification method of ultrafiltration and nanofiltration. The ultrafiltration membrane physically retains impurities such as proteins, colloids, small molecule degradation fragments, and pigment impurities at room temperature, while enriching the complete high-molecular-weight chondroitin sulfate polysaccharide component.
[0042] 3. This application uses a complex protease to hydrolyze the proteoglycans and break the peptide chains, avoiding excessive protease hydrolysis that could damage the polysaccharide backbone of chondroitin sulfate, and gently releasing the crude polysaccharide solution of chondroitin sulfate. Detailed Implementation
[0043] The present application will be further described in detail below with reference to the embodiments.
[0044] The raw materials used in the examples and comparative examples are all commercially available.
[0045] Example 1: A method for preparing chondroitin sulfate sodium, comprising the following steps: S1. Low-temperature clean pretreatment: 10kg of animal cartilage (pig nasal bone, pig rib cartilage, dry weight) raw material is crushed, washed and degreased at low temperature to obtain clean cartilage raw material; S2. Controlled microenzymatic hydrolysis extraction: The clean cartilage raw material was dispersed in 120L of buffer aqueous solution (0.1 mol / L phosphate buffer, sodium dihydrogen phosphate-disodium hydrogen phosphate buffer), stirred for 30 min, and then hydrolyzed at low temperature with a compound protease. The enzyme was inactivated at 90℃ and kept at 10 min. The crude extract was obtained by filtration to remove the residue. S3. Membrane gradient fractionation purification: The crude extract is purified by ultrafiltration-nanofiltration dual-stage membrane gradient purification to obtain a purified polysaccharide concentrate; S4, Alcohol-free green sodium salt conversion: Slow ion exchange is performed using a weak salt buffer system (0.2 mol / L sodium phosphate buffer, disodium hydrogen phosphate-sodium dihydrogen phosphate buffer); S5. Low-temperature purification and finalization: Chondroitin sulfate sodium is obtained by aseptic filtration and low-temperature vacuum drying.
[0046] The complex protease consists of trypsin, papain, and flavor protease in a mass ratio of 1:0.2:0.4.
[0047] In step S1, the particle size is 40 mesh, and the degreasing is carried out by stirring and rinsing with low-temperature clean water at a temperature of 15℃.
[0048] In step S2, the buffer aqueous solution pH=6.8, the enzymatic hydrolysis temperature is 32℃, the amount of compound enzyme added is 0.1% of the dry weight of the raw material, and the enzymatic hydrolysis time is 4 h.
[0049] In step S3, the ultrafiltration membrane has a molecular weight cutoff of 10 kDa, and the nanofiltration concentrates and desalts the water by using a nanofiltration membrane with a molecular weight cutoff of 2500 Da. The membrane is operated at room temperature to remove impurities, proteins and small molecular fragments, while retaining high molecular weight polysaccharide components.
[0050] In step S4, the weak salt buffer system has a pH of 7.6 and uses a trace amount of sodium salt gradient replacement. The pH fluctuation of the system is ≤±0.3, and no ethanol, strong base, or strong acid is added throughout the process.
[0051] The drying temperature in step S5 is -18℃.
[0052] Example 2: A method for preparing chondroitin sulfate sodium, which differs from Example 1 in that the method for preparing chondroitin sulfate sodium includes the following steps: S1. Low-temperature clean pretreatment: 10kg of animal cartilage (pig nasal bone, pig rib cartilage, dry weight) raw material is crushed, washed and degreased at low temperature to obtain clean cartilage raw material; S2. Controlled microenzymatic hydrolysis extraction: The clean cartilage raw material was dispersed in 120L of buffer aqueous solution (0.1 mol / L phosphate buffer, sodium dihydrogen phosphate-disodium hydrogen phosphate buffer), stirred for 30 min, and then hydrolyzed at low temperature with a compound protease. The enzyme was inactivated at 90℃ and kept at 10 min. The crude extract was obtained by filtration to remove the residue. S3. Membrane gradient fractionation purification: The crude extract is purified by ultrafiltration-nanofiltration dual-stage membrane gradient purification to obtain a purified polysaccharide concentrate; S4, Alcohol-free green sodium salt conversion: Slow ion exchange is performed using a weak salt buffer system (0.2 mol / L sodium phosphate buffer, disodium hydrogen phosphate-sodium dihydrogen phosphate buffer); S5. Low-temperature purification and finalization: Chondroitin sulfate sodium is obtained by aseptic filtration and low-temperature vacuum drying.
[0053] The complex protease consists of trypsin, papain, and flavor protease in a mass ratio of 1:0.1:0.6.
[0054] In step S1, the particle size is 20 mesh, and the degreasing is carried out by stirring and rinsing with low-temperature clean water at a temperature of 25°C.
[0055] In step S2, the buffer aqueous solution pH=7.5, the enzymatic hydrolysis temperature is 38℃, the amount of compound enzyme added is 0.3% of the dry weight of the raw material, and the enzymatic hydrolysis time is 2 h.
[0056] In step S3, the ultrafiltration membrane has a molecular weight cutoff of 10 kDa, and the nanofiltration concentrates and desalts the water by using a nanofiltration membrane with a molecular weight cutoff of 2500 Da. The membrane is operated at room temperature to remove impurities, proteins and small molecular fragments, while retaining high molecular weight polysaccharide components.
[0057] In step S4, the weak salt buffer system has a pH of 6.9 and uses a trace amount of sodium salt gradient replacement. The pH fluctuation of the system is ≤ ±0.3, and no ethanol, strong base, or strong acid is added throughout the process.
[0058] The drying temperature in step S5 is 5℃.
[0059] Example 3: A method for preparing sodium chondroitin sulfate, which differs from Example 1 in that the complex protease is composed of trypsin, papain, and flavor protease in a mass ratio of 1:0.02:0.8.
[0060] Example 4: A method for preparing chondroitin sulfate sodium, which differs from Example 1 in that trypsin is pretreated, 0.2 kg of hydroxyapatite nanowires (purchased from Wuhan Kemike Biomedical Technology Co., Ltd.) are dispersed in 120 L of ethanol / water (ethanol / water volume ratio 7:3) mixed solution, 4 kg of mesoporous nano silica (purchased from Hangzhou Jikang New Materials Co., Ltd.) are added, and the mixture is centrifuged, washed, and dried to obtain a composite carrier; The composite carrier was dispersed in 20 L of phosphate buffer (pH 7.4), and trypsin (enzyme / carrier mass ratio of 1:10, purchased from Hongke Biomedical Technology (Shanxi) Co., Ltd.) was added. The mixture was stirred and adsorbed at 4 °C for 12 h, and then glutaraldehyde (final mass concentration of 0.1%) was added for cross-linking for 2 h. After centrifugation and washing, immobilized trypsin was obtained.
[0061] Example 5: A method for preparing sodium chondroitin sulfate, which differs from Example 4 in that the trypsin is pretreated, and 4 kg of mesoporous nano-silica is dispersed in 120 L of ethanol / water (ethanol / water volume ratio 7:3) mixed solution, centrifuged, washed, and dried to obtain the carrier; The carrier was dispersed in 20 L of phosphate buffer (pH 7.4), and trypsin (enzyme / carrier mass ratio of 1:10) was added. The mixture was stirred and adsorbed at 4 °C for 12 h, and then glutaraldehyde (final mass concentration of 0.1%) was added for cross-linking for 2 h. After centrifugation and washing, immobilized trypsin was obtained.
[0062] Example 6: A method for preparing sodium chondroitin sulfate, which differs from Example 4 in that trypsin is pretreated, and 0.2 kg of hydroxyapatite nanowires are dispersed in 120 L of ethanol / water (ethanol / water volume ratio 7:3) mixed solution, centrifuged, washed, and dried to obtain a carrier; The carrier was dispersed in 20 L of phosphate buffer (pH 7.4), and trypsin (enzyme / carrier mass ratio of 1:10) was added. The mixture was stirred and adsorbed at 4 °C for 12 h, and then glutaraldehyde (final mass concentration of 0.1%) was added for cross-linking for 2 h. After centrifugation and washing, immobilized trypsin was obtained.
[0063] Example 7: A method for preparing chondroitin sulfate sodium, differing from Example 4 in that papain is treated. 0.8 kg of chitosan and 0.3 kg of amino acids (L-lysine, purchased from Hubei Haijia Biotechnology Co., Ltd.) are dissolved in 100 L of acetic acid solution-deionized water (acetic acid mass concentration is 1%). After mixing, 0.05 kg of papain (purchased from Jiangsu Jiujia Biotechnology Co., Ltd.) is added. 0.03 kg of genipin is added dropwise under stirring. The mixture is stirred at room temperature for 4 h to form nanogel particles. After centrifugation and washing, embedded papain is obtained.
[0064] Example 8: A method for preparing chondroitin sulfate sodium, which differs from Example 7 in that the papain is treated. 0.3 kg of amino acid (L-lysine) is dissolved in 100 L of acetic acid solution-deionized water, mixed, and then 0.05 kg of papain is added. 0.03 kg of genipin is added dropwise under stirring, and the mixture is stirred at room temperature for 4 h to form nanogel particles. After centrifugation and washing, the encapsulated papain is obtained.
[0065] Example 9: A method for preparing chondroitin sulfate sodium, which differs from Example 7 in that the papain is treated. 0.8 kg of chitosan is dissolved in 100 L of acetic acid solution-deionized water, mixed, and then 0.05 kg of papain is added. 0.03 kg of genipin is added dropwise under stirring, and the mixture is stirred at room temperature for 4 h to form nanogel particles. After centrifugation and washing, the encapsulated papain is obtained.
[0066] Example 10: A method for preparing chondroitin sulfate sodium, differing from Example 7 in that the flavor protease is treated. 0.6 kg of flavor protease (purchased from Chengdu Wanxiang Hongrun Biotechnology Co., Ltd.) is dissolved in 10 L of 0.2% diatomaceous earth aqueous solution, stirred evenly, and glutaraldehyde is added to a final mass concentration of 0.5%. The mixture is stirred and crosslinked for 3 h. Then, 1.3 kg of metal-organic framework material ZIF-8 (purchased from Xi'an Qiyue Biotechnology Co., Ltd.) is added, and the mixture is stirred at room temperature for 30 min. The precipitate is collected by centrifugation, washed, and the treated flavor protease is obtained.
[0067] Example 11: A method for preparing chondroitin sulfate sodium, which differs from Example 10 in that the flavor protease is treated. 0.6 kg of flavor protease is dissolved in an aqueous solution, stirred evenly, and glutaraldehyde is added to a final mass concentration of 0.5%. The mixture is stirred and crosslinked for 3 h. 1.3 kg of metal-organic framework material ZIF-8 is added, and the mixture is stirred at room temperature for 30 min. The precipitate is collected by centrifugation, washed, and the treated flavor protease is obtained.
[0068] Example 12: A method for preparing chondroitin sulfate sodium, which differs from Example 10 in that the flavor protease is treated. 0.6 kg of flavor protease is dissolved in 10 L of diatomaceous earth aqueous solution with a mass fraction of 0.2%, stirred evenly, and glutaraldehyde is added to a final mass concentration of 0.5%. The mixture is stirred and crosslinked for 3 h. The precipitate is collected by centrifugation, washed, and the treated flavor protease is obtained.
[0069] Comparative Example 1 A method for preparing chondroitin sulfate sodium differs from Example 1 in that trypsin is used instead of the complex protease.
[0070] Comparative Example 2 A method for preparing chondroitin sulfate sodium differs from Example 1 in that papain is used instead of the complex protease.
[0071] Comparative Example 3 A method for preparing chondroitin sulfate sodium differs from Example 1 in that the complex protease is replaced by a flavor protease.
[0072] The performance of the sodium chondroitin sulfate prepared in Examples 1-12 and Comparative Examples 1-3 was tested. The yield and purity of sodium chondroitin sulfate obtained in Examples 1-12 and Comparative Examples 1-3 were tested. Testing basis: As specified in the "Chondroitin Sulfate Sodium" section of the 2020 edition of the Pharmacopoeia of the People's Republic of China, Part II; Yield calculation formula: Yield (%) = (mass of pure sodium chondroitin sulfate in finished product / theoretical content of sodium chondroitin sulfate in the dry weight of raw cartilage) × 100%. Test results are shown in Table 1.
[0073] Table 1 Test data for the examples and comparative examples
[0074] As shown in Table 1, the chondroitin sulfate sodium prepared in Examples 1-2 of this application has good purity, yield, and low impurities. Specifically, Example 1 has a yield of 10.5%, a purity of 92.5%, and a chloride content of <0.5%. It is evident that the chondroitin sulfate sodium prepared in this application has an intact polysaccharide backbone, low degradation rate, high purity, and uniform molecular weight distribution, resulting in high-purity, high-molecular-weight, and highly active chondroitin sulfate sodium.
[0075] Example 3 altered the ratio of trypsin, papain, and flavor protease. As shown in Table 1, the yield and purity of chondroitin sulfate sodium in Example 3 were slightly lower than those in Examples 1-2. This indicates that the combination of the three enzymes achieves controllable microenzymatic hydrolysis, and their synergistic effect enables efficient extraction while avoiding excessive enzymatic hydrolysis that could lead to degradation of chondroitin sulfate polysaccharide chains, thus reducing the level of protein impurities in the liquid.
[0076] Example 4 involved pretreating trypsin, while Examples 5-6 involved pretreating trypsin without adding hydroxyapatite nanowires or mesoporous silica nanofibers. Table 1 shows that the yield and purity of chondroitin sulfate sodium in Example 4 were higher than in Examples 1-2, while the yield and purity of Examples 5-6 were lower than in Example 4, but better than in Examples 1-2. This indicates that mesoporous silica provides high loading sites, and hydroxyapatite nanowires have an affinity for and adsorption capacity for proteins, improving the stability of trypsin. Stable immobilized enzymes enable more precise and gentler enzymatic hydrolysis, achieving the goal of breaking proteoglycan-linked peptide chains without disintegrating the polysaccharide backbone.
[0077] Example 7 involved treating papain, while Examples 8-9 did not add chitosan or amino acids during the pretreatment of papain. Table 1 shows that the yield and purity of chondroitin sulfate sodium in Example 7 were higher than in Example 4, while the yield and purity of Examples 8-9 were lower than in Example 7, but better than in Example 4. This indicates that genipin undergoes covalent cross-linking with the amino groups of chitosan and amino acids, forming in-situ encapsulated papain nanogel particles. This in-situ encapsulation of papain through a three-dimensional polymer network enhances the enzyme's environmental stability. The nanogel structure facilitates substrate mass transfer, resulting in high enzyme activity retention and excellent biocompatibility.
[0078] Example 10 involved treating the flavor protease, while Examples 11-12 did not include diatomaceous earth or metal-organic framework materials during the pretreatment of the flavor protease. Table 1 shows that the yield and purity of chondroitin sulfate sodium in Example 10 were higher than in Example 7, while the yield and purity of Examples 11-12 were lower than in Example 10, but better than in Example 7. This indicates that the covalent bonding between the flavor protease and diatomaceous earth is achieved through the dialdehyde group of glutaraldehyde. Utilizing the porous adsorption of diatomaceous earth and the large specific surface area and microporous cage confinement effect of ZIF-8, enzyme leakage is reduced while preserving enzyme catalytic activity.
[0079] Comparative Examples 1-3 used trypsin, papain, and flavor protease to replace the complex protease, respectively. Table 1 shows that the yield and purity of chondroitin sulfate sodium in Comparative Examples 1-3 were worse than in Examples 1-2. This indicates that trypsin preferentially hydrolyzes the lysine and arginine sites in the core protein of proteoglycans, directionally cleaving the protein backbone of the proteoglycans and releasing the chondroitin sulfate sugar chains from the protein calcium phosphate matrix. Papain hydrolyzes some collagen, denatured proteins, and hydrophobic proteins in cartilage, breaking down the cartilage fibrous network structure and further releasing the encapsulated proteoglycans. Flavor protease further degrades the large polypeptides produced by the two endonucleases into small short peptides, improving the purity of chondroitin sulfate.
[0080] This specific embodiment is merely an explanation of this application and is not intended to limit it. After reading this specification, those skilled in the art can make modifications to this embodiment without contributing any inventive step, but such modifications are protected by patent law as long as they fall within the scope of the claims of this application.
Claims
1. A method for preparing sodium chondroitin sulfate, characterized in that, Includes the following steps: S1. Low-temperature clean pretreatment: The animal cartilage raw material is crushed, washed, and degreased at low temperature to obtain clean cartilage raw material; S2. Controlled microenzymatic hydrolysis extraction: The clean cartilage raw material is dispersed in a buffer aqueous solution, stirred, and subjected to low-temperature enzymatic hydrolysis using a compound protease. The crude extract is obtained by filtration to remove residue. S3. Membrane gradient fractionation purification: The crude extract is purified by ultrafiltration-nanofiltration dual-stage membrane gradient purification to obtain a purified polysaccharide concentrate; S4, alcohol-free green sodium salt conversion: ion exchange is carried out using a weak salt buffer system; S5. Low-temperature purification and finalization: Chondroitin sulfate sodium is obtained by aseptic filtration and low-temperature vacuum drying.
2. The method for preparing chondroitin sulfate sodium according to claim 1, characterized in that, The complex protease is composed of trypsin, papain, and flavor protease in a mass ratio of 1:0.1-0.2:0.4-0.
6.
3. The method for preparing chondroitin sulfate sodium according to claim 2, characterized in that, Trypsin was pretreated, hydroxyapatite nanowires were dispersed in an ethanol / water mixture, mesoporous silica nanofibers were added, and the mixture was centrifuged, washed, and dried to obtain a composite carrier. The composite carrier was dispersed in phosphate buffer, trypsin was added, and after stirring, glutaraldehyde was added for cross-linking. After centrifugation and washing, immobilized trypsin was obtained.
4. The method for preparing chondroitin sulfate sodium according to claim 2, characterized in that, Papain was treated by dissolving chitosan and amino acids in acetic acid-deionized water, mixing them, adding papain, and then adding genipin dropwise while stirring to form nanogel particles. After centrifugation and washing, encapsulated papain was obtained.
5. The method for preparing chondroitin sulfate sodium according to claim 2, characterized in that, The flavor protease was treated by dissolving it in an aqueous solution of diatomaceous earth, stirring until homogeneous, adding glutaraldehyde, continuing stirring, adding a metal-organic framework, stirring at room temperature, centrifuging to collect the precipitate, washing, and obtaining the treated flavor protease.
6. The method for preparing chondroitin sulfate sodium according to claim 1, characterized in that, In step S1, the particle size is 20-40 mesh, and the degreasing is carried out by stirring and rinsing with low-temperature clean water at a temperature of 15-25℃.
7. The method for preparing chondroitin sulfate sodium according to claim 1, characterized in that, In step S2, the buffer solution has a pH of 6.8-7.5 and the enzymatic hydrolysis temperature is 32-38℃.
8. A method for preparing chondroitin sulfate sodium according to claim 1, characterized in that, In step S4, the pH of the weak salt buffer system is 6.9-7.6, and the pH fluctuation of the system is ≤±0.
3.
9. The method for preparing chondroitin sulfate sodium according to claim 1, characterized in that, The drying temperature for step S5 is -18 to 5℃.
10. The application of chondroitin sulfate prepared by the method of any one of claims 1-9 in the fields of food, health products, cosmetics, and biomedicine.
